SPY756.68−0.41%QQQ684.68−0.83%BTC/USD73,527.00−0.54%DIA524.440.00%GLD359.77−1.48%TLT81.09+0.21%

Syndax Pharmaceuticals Inc

SNDXNASDAQ

Trade with Public

$9.59

0.11.05%

Last update: Nov 12, 4:09 AM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Syndax Pharmaceuticals (SNDX) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Syndax Pharmaceuticals (SNDX) stock.

Analyst Consensus — 13 Analysts

12Buy

1Hold

# Analysts13

Latest Upgrades and Downgrades for Syndax Pharmaceuticals Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	HC Wainwright & Co.	Andres Y. Maldonado	PT Cut	Buy	$38→$36
—	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$38
—	UBS	David Dai	PT Cut	Buy	$37→$33
—	JP Morgan	Anupam Rama	PT Cut	Overweight	$44→$40
—	HC Wainwright & Co.	Andres Y. Maldonado	PT Cut	Buy	$40→$38
—	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$40
—	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$40
—	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$40
—	UBS	David Dai	PT Cut	Buy	$38→$37
—	Barclays	Etzer Darout	PT Raise	Overweight	$35→$37
—	Goldman Sachs	Corinne Johnson	PT Raise	Buy	$28→$34
—	Mizuho	Salim Syed	PT Cut	Outperform	$45→$43
—	Jefferies	Faisal Khurshid	Assumes	Buy	$48→$40
—	JP Morgan	Anupam Rama	PT Raise	Overweight	$33→$45
—	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$51→$57
—	BTIG	Justin Zelin	Maintained	Buy	$56
—	Barclays	Etzer Darout	PT Raise	Overweight	$22→$35
—	JP Morgan	Anupam Rama	PT Cut	Overweight	$40→$33
—	UBS	David Dai	PT Raise	Buy	$35→$38
—	Barclays	Peter Lawson	PT Raise	Overweight	$19→$22

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals (SNDX) Stock Price Target 2026

Latest Upgrades and Downgrades for Syndax Pharmaceuticals Stock

Syndax Pharmaceuticals (SNDX) Stock Price Target 2026

Latest Upgrades and Downgrades for Syndax Pharmaceuticals Stock

Analyst Ratings News

Apple To $350? Here Are 10 Top Analyst Forecasts For Tuesday

PRO
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $36

PRO
HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $38 Price Target

PRO
UBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $33

PRO
JP Morgan Maintains Overweight on Syndax Pharmaceuticals, Lowers Price Target to $40

PRO
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $38

People Also Watch

People Also Watch

Analyst Ratings News

Apple To $350? Here Are 10 Top Analyst Forecasts For Tuesday

PRO
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $36

PRO
HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $38 Price Target

PRO
UBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $33

PRO
JP Morgan Maintains Overweight on Syndax Pharmaceuticals, Lowers Price Target to $40

PRO
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $38

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals (SNDX) Stock Price Target 2026

Latest Upgrades and Downgrades for Syndax Pharmaceuticals Stock

Syndax Pharmaceuticals (SNDX) Stock Price Target 2026

Latest Upgrades and Downgrades for Syndax Pharmaceuticals Stock

Analyst Ratings News

Apple To $350? Here Are 10 Top Analyst Forecasts For Tuesday

PROHC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $36

PROHC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $38 Price Target

PROUBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $33

PROJP Morgan Maintains Overweight on Syndax Pharmaceuticals, Lowers Price Target to $40

PROHC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $38

People Also Watch

People Also Watch

Analyst Ratings News

Apple To $350? Here Are 10 Top Analyst Forecasts For Tuesday

PROHC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $36

PROHC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $38 Price Target

PROUBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $33

PROJP Morgan Maintains Overweight on Syndax Pharmaceuticals, Lowers Price Target to $40

PROHC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $38

PRO
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $36

PRO
HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $38 Price Target

PRO
UBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $33

PRO
JP Morgan Maintains Overweight on Syndax Pharmaceuticals, Lowers Price Target to $40

PRO
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $38

PRO
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $36

PRO
HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $38 Price Target

PRO
UBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $33

PRO
JP Morgan Maintains Overweight on Syndax Pharmaceuticals, Lowers Price Target to $40

PRO
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $38